Figure S1 from Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors

Open Access

Publisher Website

31 March 2023

other
Published by American Association for Cancer Research (AACR)

https://doi.org/10.1158/1078-0432.22458960.v1

Abstract

Figure S1. Seventeen patients were tested with IFN-γ ELISPOT assay.

Keywords